Notice of Results
hVIVO plc has announced that its interim results for the six months ended 30 June 2026 will be released on Tuesday, 15 September 2026, with an analyst briefing scheduled for the same day at 11:00 AM BST. The company's Chief Executive Officer and Chief Financial Officer will also provide a live investor presentation on the Investor Meet Company platform at 5:30 PM BST on 15 September 2026, allowing shareholders to submit questions in advance.
Select text to share a quote on X · sign in to keep highlights & notes in your HVO notes
London, UK - 4 September 2026, hVIVO plc (AIM: HVO), a purpose-built, full service international clinical development partner and the world leader in human challenge clinical trials, announces that it will release its interim results for the six months ended 30 June 2026 on Tuesday 15 September 2026.
Analyst briefing
A briefing open to equity research analysts will take place on Tuesday 15 September 2026 at 11.00am BST. To register and for more details please contact hVIVO@icrhealthcare.com.
Investor presentation
Yamin 'Mo' Khan, Chief Executive Officer, and Stephen Pinkerton, Chief Financial Officer, will provide a live presentation relating to the Interim Results via the Investor Meet Company platform on 15 September 2026 at 5.30pm BST.
| Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker) | +44 (0)20 7220 0500 |
| Geoff Nash, Callum Davidson, Nigel Birks | |
| Peel Hunt LLP (Joint Broker) | +44 (0)20 7418 8900 |
| James Steel, Dr Christopher Golden | |
| Davy (Joint Broker) | +353 (0) 1 679 6363 |
Anthony Farrell, Niall Gilchrist
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.